STRO SUTRO BIOPHARMA INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 17 analyst firms say about SUTRO BIOPHARMA INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
17 rated views · 18 analyst/firm records · 17 firms
Radar score
- Russell 2000 · Top Picks · 6MStrong · #4 in the index94
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8058
Recent analyst activity · last 90 days
Our tracked history has 11 reports on STRO from 9 analyst firms in the last 90 days (17 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 lowered it and 4 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wells Fargo raised its target from $27.00 (set 24 Mar 2026) to $49.00 on 30 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Lukas Shumway | Buy | 28 May 2026 | 56.00 USD |
| Citigroup | Unnamed analyst | Buy | 13 Aug 2026 | — |
| Citizens JMP | Reni Benjamin | Buy | 13 Aug 2026 | 34.00 USD |
| Deutsche Bank | James Shin | Buy | 25 Mar 2026 | 55.00 USD |
| H.C. Wainwright | Andres Y. Maldonado | Buy | 16 Oct 2026 | 50.00 USD · 12 Aug 2026 |
| Jefferies | Roger Song | Buy | 24 Mar 2026 | 49.00 USD |
| Leerink Partners | Andrew Berens | Buy | 7 Apr 2026 | Conflicting reports · excluded |
| Lifesci Capital | Charles Zhu | Buy | 1 May 2026 | 54.00 USD |
| Mizuho | Graig Suvannavejh | Buy | 16 Sep 2026 | 50.00 USD |
| Mizuho | Salim Syed | Buy | 16 Sep 2026 | — |
| Piper Sandler | Edward A Tenthoff | Buy | 12 Aug 2026 | — |
| Stifel | Laura Prendergast | Buy | 7 Aug 2026 | 48.00 USD |
| TD Cowen | Tara Bancroft | Buy | 24 Mar 2026 | — |
| Truist | Supawat Thongthip | Buy | 13 Aug 2026 | 50.00 USD |
| Wedbush | David Nierengarten | Buy | 15 Oct 2026 | 60.00 USD |
| Weiss Ratings | Unnamed analyst | — | 19 Oct 2026 | — |
| Wells Fargo | Derek C Archila | Buy | 30 Sep 2026 | 49.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:25 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.